$HSCS
HeartSciences Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024136607 Filed on December 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $786.1K
YoY Change -3.55%
% of Gross Profit
Research & Development $1.199M
YoY Change 58.32%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.985M
YoY Change 26.25%
Operating Profit -$1.985M
YoY Change 26.44%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$97.89K
YoY Change -45.14%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.083M
YoY Change 19.13%
Net Earnings / Revenue
Basic Earnings Per Share -$2.27
Diluted Earnings Per Share -$2.27
COMMON SHARES
Basic Shares Outstanding 917.4K
Diluted Shares Outstanding 917.4K

Balance Sheet

Concept 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.052M
Short-Term Investments
Other Short-Term Assets $40.37K
YoY Change 0.0%
Inventory $652.9K
Prepaid Expenses $239.6K
Receivables
Other Receivables
Total Short-Term Assets $5.689M
YoY Change 213.93%
LONG-TERM ASSETS
Property, Plant & Equipment $77.07K
YoY Change 44.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.088M
YoY Change 275.47%
TOTAL ASSETS
Total Short-Term Assets $5.689M
Total Long-Term Assets $2.088M
Total Assets $7.777M
YoY Change 228.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $276.8K
YoY Change -74.56%
Accrued Expenses $369.7K
YoY Change -52.16%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.303M
YoY Change -6.47%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $457.8K
YoY Change -5.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.303M
Total Long-Term Liabilities $457.8K
Total Liabilities $3.761M
YoY Change -6.41%
SHAREHOLDERS EQUITY
Retained Earnings -$71.50M
YoY Change 11.89%
Common Stock $948.00
YoY Change -91.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.017M
YoY Change
Total Liabilities & Shareholders Equity $7.777M
YoY Change 228.38%

Cashflow Statement

Concept 2024 Q4
OPERATING ACTIVITIES
Net Income -$2.083M
YoY Change 19.13%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001468492
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41422
dei Entity Registrant Name
EntityRegistrantName
HEARTSCIENCES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1344466
dei Entity Address Address Line1
EntityAddressAddressLine1
550 Reserve Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 360
dei Entity Address City Or Town
EntityAddressCityOrTown
Southlake
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76092
dei City Area Code
CityAreaCode
682
dei Local Phone Number
LocalPhoneNumber
237-7781
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
980321
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4052120
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5807648
CY2024Q4 us-gaap Inventory Net
InventoryNet
652907
CY2024Q2 us-gaap Inventory Net
InventoryNet
629179
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
239629
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
183704
CY2024Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40374
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
40374
CY2024Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
704044
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
692988
CY2024Q4 us-gaap Assets Current
AssetsCurrent
5689074
CY2024Q2 us-gaap Assets Current
AssetsCurrent
7353893
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77069
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97991
CY2024Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1592764
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1589246
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
418334
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
461983
CY2024Q4 us-gaap Assets
Assets
7777241
CY2024Q2 us-gaap Assets
Assets
9503113
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
276848
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
448183
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
369673
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
398331
CY2024Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5096
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
268813
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
110645
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
102293
CY2024Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2366800
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
500000
CY2024Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
173644
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34147
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3302706
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1751767
CY2024Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
49470
CY2024Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
32103
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
376241
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
434045
CY2024Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
457814
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
434045
CY2024Q4 us-gaap Liabilities
Liabilities
3760520
CY2024Q2 us-gaap Liabilities
Liabilities
2185812
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
947821
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
947821
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
676598
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
676598
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
948
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
677
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75512406
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74678650
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71497013
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67362406
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
4016721
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
7317301
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7777241
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9503113
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3900
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3900
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
1520
us-gaap Cost Of Revenue
CostOfRevenue
1520
CY2023Q4 us-gaap Gross Profit
GrossProfit
2380
us-gaap Gross Profit
GrossProfit
2380
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1198965
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
757303
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2423896
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1322935
CY2024Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
786068
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
815020
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1636804
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1580043
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
1985033
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
1572323
us-gaap Operating Expenses
OperatingExpenses
4060700
us-gaap Operating Expenses
OperatingExpenses
2902978
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1985033
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1569943
us-gaap Operating Income Loss
OperatingIncomeLoss
-4060700
us-gaap Operating Income Loss
OperatingIncomeLoss
-2900598
CY2024Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
117598
CY2023Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
178438
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
140124
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
214698
CY2024Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
19713
CY2023Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
66217
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
63
CY2024Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-97885
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-178435
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-73907
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-214635
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-2082918
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1748378
us-gaap Net Income Loss
NetIncomeLoss
-4134607
us-gaap Net Income Loss
NetIncomeLoss
-3115233
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.92
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-29.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-29.23
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
917445
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
917445
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109841
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109841
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
847990
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
847990
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106582
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106582
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
5933958
CY2024Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44561
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-2082918
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
4016721
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-519702
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105840
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1748378
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1649682
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
7317301
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10046
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
99115
us-gaap Net Income Loss
NetIncomeLoss
-4134607
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
4016721
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
230557
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
232614
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
230486
us-gaap Net Income Loss
NetIncomeLoss
-3115233
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1649682
us-gaap Net Income Loss
NetIncomeLoss
-4134607
us-gaap Net Income Loss
NetIncomeLoss
-3115233
us-gaap Depreciation
Depreciation
24079
us-gaap Depreciation
Depreciation
14974
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43649
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
26393
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
65970
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
82876
us-gaap Share Based Compensation
ShareBasedCompensation
99115
us-gaap Share Based Compensation
ShareBasedCompensation
230486
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
10046
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
232614
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3900
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23728
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1520
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-205321
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-151833
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
11056
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
448250
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-171335
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
456928
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-260272
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-38171
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-49452
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
15478
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4202270
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2392452
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3518
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3157
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6862
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6675
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6862
hscs Issuance Of Common Stock Under Equity Line Net Of Fees
IssuanceOfCommonStockUnderEquityLineNetOfFees
724866
hscs Issuance Of Common Stock Under Equity Line Net Of Fees
IssuanceOfCommonStockUnderEquityLineNetOfFees
671894
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
334249
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
121749
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
167152
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2453417
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
838991
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1755528
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1560323
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5807648
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1660467
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4052120
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100144
hscs Issuance Of Common Stock Resulting From Reverse Stock Split
IssuanceOfCommonStockResultingFromReverseStockSplit
94
hscs Issuance Of Common Stock For Series C Preferred Conversions
IssuanceOfCommonStockForSeriesCPreferredConversions
2
hscs Issuance Of Common Stock As Consideration For Consulting Services
IssuanceOfCommonStockAsConsiderationForConsultingServices
-100000
hscs Issuance Of Common Stock Warrants In Connection With Msw Note
IssuanceOfCommonStockWarrantsInConnectionWithMSWNote
165751
hscs Issuance Of Common Stock Warrants As Consideration For Consulting Services
IssuanceOfCommonStockWarrantsAsConsiderationForConsultingServices
7561
hscs Issuance Of Common Stock Warrants In Connection With Note Extensions
IssuanceOfCommonStockWarrantsInConnectionWithNoteExtensions
59302
hscs Financed Insurance Premiums
FinancedInsurancePremiums
244259
hscs Financed Insurance Premiums
FinancedInsurancePremiums
277176
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-100 reverse stock
CY2024Q2 hscs Pre Reverse Split Common Stock Outstanding
PreReverseSplitCommonStockOutstanding
100
CY2024Q2 hscs Pre Reverse Split Common Stock Issued
PreReverseSplitCommonStockIssued
100
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71500000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67400000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p>
CY2024Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
322996
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
322996
CY2024Q4 hscs Inventory Sub Assemblies
InventorySubAssemblies
371164
CY2024Q2 hscs Inventory Sub Assemblies
InventorySubAssemblies
347436
CY2024Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21741
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21741
CY2024Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
22581
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
22581
CY2024Q4 hscs Inventory Reserve For Obsolescence
InventoryReserveForObsolescence
85575
CY2024Q2 hscs Inventory Reserve For Obsolescence
InventoryReserveForObsolescence
85575
CY2024Q4 us-gaap Inventory Net
InventoryNet
652907
CY2024Q2 us-gaap Inventory Net
InventoryNet
629179
hscs Useable Life Of Device
UseableLifeOfDevice
P7Y
CY2024Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
600907
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
597750
CY2024Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
523838
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
499759
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77069
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97991
CY2024Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
704044
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
692988
CY2024Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2024Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2024Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2024Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2366800
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
500000
CY2024Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
49470
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
20
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
947821
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
676598
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
676598
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
271223
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
947821
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000000
us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2024 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2024Q2 hscs Warrants Outstanding And Exercisable
WarrantsOutstandingAndExercisable
56555
CY2024Q2 hscs Class Of Warrant Or Right Weighted Average Strike Price Per Share
ClassOfWarrantOrRightWeightedAverageStrikePricePerShare
182
hscs Warrants Outstanding And Exercisable Granted
WarrantsOutstandingAndExercisableGranted
2500
hscs Exercise Price Per Share Granted
ExercisePricePerShareGranted
5.15
hscs Class Of Warrant Or Right Weighted Average Strike Price Per Share Granted
ClassOfWarrantOrRightWeightedAverageStrikePricePerShareGranted
5.15
CY2024Q4 hscs Warrants Outstanding And Exercisable
WarrantsOutstandingAndExercisable
59055
CY2024Q4 hscs Class Of Warrant Or Right Weighted Average Strike Price Per Share
ClassOfWarrantOrRightWeightedAverageStrikePricePerShare
174.42
hscs Share Based Compensation Arrangement By Share Based Payment Award Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10413290
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11378409
CY2024Q4 hscs Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
993377
CY2024Q2 hscs Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
833918
CY2024Q4 hscs Deferred Tax Assets Stock Option And Warrant Payments
DeferredTaxAssetsStockOptionAndWarrantPayments
715020
CY2024Q2 hscs Deferred Tax Assets Stock Option And Warrant Payments
DeferredTaxAssetsStockOptionAndWarrantPayments
694206
CY2024Q4 hscs Deferred Tax Liabilities Accumulated Depreciation
DeferredTaxLiabilitiesAccumulatedDepreciation
-1102896
CY2024Q2 hscs Deferred Tax Liabilities Accumulated Depreciation
DeferredTaxLiabilitiesAccumulatedDepreciation
3339
CY2024Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
816075
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
255600
CY2024Q4 hscs Deferred Tax Assets Research And Development Warrants
DeferredTaxAssetsResearchAndDevelopmentWarrants
21488
CY2024Q2 hscs Deferred Tax Assets Research And Development Warrants
DeferredTaxAssetsResearchAndDevelopmentWarrants
21488
CY2024Q4 hscs Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
14062146
CY2024Q2 hscs Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
13180282
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14062146
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13180282
CY2024Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
On September 27, 2022, the Company entered into the First Amendment to Lease (the “Lease Amendment”), which amended the Lease Agreement to document the exercise of its option to extend the term of the lease for an additional 64 months, commencing February 1, 2023, and expiring on May 31, 2028 (the “Extension Term”). Pursuant to the amendment, the Company will pay initial monthly payments of $13,129, beginning February 2023, subject to 3% annual increases.
hscs Operating Lease Option To Extend Additional Lease Term
OperatingLeaseOptionToExtendAdditionalLeaseTerm
P64M
hscs Operating Lease Commencing Date
OperatingLeaseCommencingDate
2023-02-01
hscs Operating Lease Expiring Date
OperatingLeaseExpiringDate
2028-05-31
us-gaap Operating Lease Payments
OperatingLeasePayments
13129
hscs Operating Lease Percentage Of Annual Increase
OperatingLeasePercentageOfAnnualIncrease
0.03
hscs Operating Leases Rent Expense
OperatingLeasesRentExpense
74000
CY2024Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.12
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
418334
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
110645
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
376241
CY2024Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
486886
CY2024Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2024Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
80748
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
165190
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
169307
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
173559
CY2024Q4 hscs Lessee Operating Lease Liability To Be Paid Thereafter
LesseeOperatingLeaseLiabilityToBePaidThereafter
14493
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
603297
CY2024Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
116411
CY2024Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
486886
CY2024Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-136607-index-headers.html Edgar Link pending
0000950170-24-136607-index.html Edgar Link pending
0000950170-24-136607.txt Edgar Link pending
0000950170-24-136607-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hscs-20241031.htm Edgar Link pending
hscs-20241031.xsd Edgar Link pending
hscs-ex31_1.htm Edgar Link pending
hscs-ex31_2.htm Edgar Link pending
hscs-ex32_1.htm Edgar Link pending
hscs-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
hscs-20241031_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable